The use of 3-carboxy - n-ethyl-n - dimetilpropan, N - 1 - aminio or a pharmaceutically acceptable Salt thereof in the treatment of Atherosclerosis

• 收藏
• 分享

专利权人:

JOINT STOCK COMPANY GRINDEKS

发明人:

OSVALDS PUGOVICS,MAIJA DAMBROVA,JANIS KUKA,EDGARS LIEPINS,EINARS LOZA,ILMARS STONANS,IVARS KALVINS,REINIS VILSKERSTS

申请号：

ARP130104820

公开号：

AR094084A1

申请日:

2013.12.18

申请国别(地区):

AR

年份:

2015

代理人:

摘要：

The use of 3-carboxy - n-ethyl-n - dimetilpropan, N - 1 - aminio and its pharmaceutically acceptable salts, hydrogen fumarate 3-carboxy - n-ethyl-n - dimetilpropan, N - 1 - aminio and dihydrogen phosphate 3-carboxy - n-ethyl-n, N - dimetilpropan - 1 - aminio, in the Prevention and Treatment of Atherosclerosis.El uso de 3-carboxi-N-etil-N,N-dimetilpropan-1-aminio y de sus sales farmacéuticamente aceptables: fumarato de hidrógeno de 3-carboxi-N-etil-N,N-dimetilpropan-1-aminio y fosfato de dihidrógeno 3-carboxi-N-etil-N,N-dimetilpropan-1-aminio, en la prevención y el tratamiento de la aterosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/